Stay updated on Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision indicator changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check13 days agoChange DetectedA site-wide notice announces that federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” under Executive Order 14434 during the transition.SummaryDifference0.5%

- Check20 days agoChange DetectedThe website’s displayed revision changed from v3.7.1 to v3.7.2; the clinical study record content remains unchanged.SummaryDifference0.1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov site footer now identifies the release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check48 days agoChange DetectedA new Revision: v3.7.0 was added to the study's version history, and the previous Revision: v3.6.6 was removed. This reflects an update to the page's revision metadata in the Record History view.SummaryDifference0.1%

- Check62 days agoChange DetectedA new version entry (version 28) with a Study Status update dated 2026-09-01 was added on 2026-09-03. A prior version dated 2026-06-22 was removed.SummaryDifference0.3%

Stay in the know with updates to Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page.